
On June 9, 2010, the $1.3 billion acquisition of Eclipsys Corporation by Allscripts-Misys Healthcare Solutions, Inc. was announced. Eclipsys is a vendor of primarily inpatient, but also ambulatory EMRs, while Allscripts has focused on the ambulatory market exclusively. In thinking about the upcoming merger, the ambulatory EMR picture just sounded really confusing. While we published a Perspective report last week covering what we feel will be the implications of the merger for hospitals and practices using Eclipsys and Allscripts products, we found that listing and counting the ambulatory EMRs started to make the picture (and the potential issues for end users) a little clearer.

To demonstrate meaningful use of electronic health records and thus qualify for incentive payments under the American Recovery and Reinvestment Act of 2009 (ARRA), healthcare organizations will have to invest in health information exchange (HIE) technologies. David Blumenthal, M.D., National Coordinator for Health Information Technology, has made it very clear that information should follow the patient "across the enterprise and among competing entities." The HIE market is characterized by a number of suppliers offering a wide variety of technologies and strategies to exchange health information including integration platforms, data aggregation, physician portals, and composite applications. There is a not a one-size-fits-all solution.

On March 31, 2010, the Drug Enforcement Agency (DEA) published a rule change that will pave the way for widespread provider adoption of e-prescribing. The new Interim Final Rule removes one of the major obstacles to e-prescribing -- the need to maintain a paper process for the estimated 11-13% of prescriptions written for controlled substances. This restriction has long served as a deterrent for adopters, despite the clear advantages of e-prescribing. It has been almost two years since the DEA published the Notice of Proposed Rulemaking, and the new rule still contains a complex two-factor authentication requirement for e-prescribers, but is expected nonetheless to improve adoption of e-prescribing.

Last week most of our healthcare team, including me, Lynne Dunbrack and Janice Young, headed to Atlanta for the HIMSS 2010 event. The change in energy at the event from 2009 was apparent from the moment we arrived. While the atmosphere at HIMSS 2009 was laced with cautious optimism as providers examined the HIT provisions of the recently-published American Recovery and Reinvestment Act, it was clear in the first hours of HIMSS 2010 that the pace had shifted and action and investment were underway.

With the passing of the HITECH Act in February of 2009, providers gained an unprecedented opportunity to receive incentive payments for implementing and using eligible electronic medical records (EMRs) under the conditions laid out in the law. In order to take advantage of the subsidies, providers must implement and demonstrate meaningful use of the EMR technology by specific deadlines, beginning in 2010. This incentive is driving interest in EMRs in all types of ambulatory practices.

Achieving “meaningful use” is the new holy grail in the realm of electronic medical records (EMRs) and electronic health records (EHRs). The HIT Policy Committee convened last Friday to hear from the various workgroups and receive an update from the HIT Standards Committee. The Meaningful Use Workgroup did not recommend any changes to the second draft of its Meaningful Use Matrix, which was presented at the last HIT Policy Committee meeting on July 16, 2009. The Workgroup did present a timeline for its activities over the next 12 months. Notable among the activities is that an assessment of the industry’s preparedness for meeting the 2011 objectives will not take place until Q410. It would seem, especially when one considers the low adoption rates of EMRs, EHRs, computerized physician order entry (CPOE), and health information exchange (HIE) technologies, that such an evaluation should have taken place before the Meaningful Use Matrix was developed. A case in point is the aggressive timeline for 100% use of CPOE.

Last Friday, August 14, 2009, the HIT Policy Committee met and adopted additional recommendations for its definition of meaningful use, a key requirement U.S. providers must demonstrate to access stimulus funding for investment in electronic medical records (EMRs). Friday's HIT Policy Committee publications included an update from the Meaningful Use Workgroup, a presentation from the Health Information Exchange Workgroup and a Review of Initial Recommendations by the Certification and Adoption Workgroup. All of the proceedings can be accessed from the HIT Policy Committee's webpage.

On June 16, 2009, the Health IT Policy Committee published a draft description of the definition of meaningful use of EMRs by provider organizations. The published materials included a presentation, a preamble document, and a matrix summarizing the priorities, goals, objectives and measures for meaningful use. Health Industry Insights expects to provide analysis in this community forum in the upcoming days, with more to come in our reports and publications. The deadline for public comments on the definition to the Health IT Policy Committee is June 26, 2009.

For hospitals to maximize their incentives payments, especially those that have not begun to invest in the requisite healthcare information technology (HIT), they must act swiftly. After all they can begin qualifying as soon as October 1, 2010. But there are so many looming issues – "What does meaningful use mean?", "Who will be the certifying body?" – not the least of which is the economic crisis thwarting HIT investment in advance of the incentive payments to come in the new few years.

EMR applications automate vast amounts of mission-critical functionality in the provider setting. With over 100 vendors to choose from and looming deadlines for implementation and demonstrating meaningful use to receive stimulus payments, inpatient and ambulatory facilities are faced with difficult decisions. For this reason, Health Industry Insights is beginning its 2nd annual EMR/EHR Short List research program. The Short List is designed to offer providers selection tools that differentiate vendor-supplied EMRs on the basis of customizable characteristics that are critical to their organizations. In order to create the Short Lists, I have been speaking with providers in the trenches in order to present the hard facts on their EMR decisions, the day-to-day issues they face and the best practices they're using.